BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6133223)

  • 1. Presynaptic action of trifluoperazine at the frog neuromuscular junction.
    Publicover SJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):83-8. PubMed ID: 6133223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine, but not chlorpromazine sulphoxide, stimulates transmitter release from motor nerve terminals.
    Sahaf ZY; Publicover SJ
    Brain Res; 1987 Dec; 437(2):397-401. PubMed ID: 2893656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of spontaneous transmitter release at the frog neuromuscular junction by 12-O-tetradecanoylphorbol-13-acetate occurs in the absence of extracellular Ca2+ and is enhanced by depolarization.
    Light PE; Sahaf ZY; Publicover SJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):339-44. PubMed ID: 2907607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trifluoperazine-sensitive activation of the spontaneous transmitter release at the frog motor endplates by low doses of procaine.
    Brănişteanu DD; Brănişteanu DD; Haulică ID
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):257-61. PubMed ID: 2891040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ca2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction.
    Katz E; Ferro PA; Cherksey BD; Sugimori M; Llinás R; Uchitel OD
    J Physiol; 1995 Aug; 486 ( Pt 3)(Pt 3):695-706. PubMed ID: 7473230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of spontaneous release at frog junctions on synaptic strength, external calcium and terminal length.
    Grinnell AD; Pawson PA
    J Physiol; 1989 Nov; 418():397-410. PubMed ID: 2576068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of trifluoperazine and promethazine on the release of transmitter quanta at the mouse neuromuscular junction.
    Nishimura M; Komatsu R; Taquahashi Y; Shimizu Y; Satoh E
    J Peripher Nerv Syst; 1998; 3(2):111-5. PubMed ID: 10959244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of lindane in accelerating the spontaneous release of transmitter at the frog neuromuscular junction.
    Publicover SJ; Duncan CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):179-82. PubMed ID: 91977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lead on neuromuscular transmission in the frog.
    Manalis RS; Cooper GP; Pomeroy SL
    Brain Res; 1984 Feb; 294(1):95-109. PubMed ID: 6320979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of spontaneous transmitter release by the membrane ligand cationized ferritin.
    Publicover SJ
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):246-8. PubMed ID: 6121298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alteration of nerve terminal Ca2+ regulation on increased spontaneous quantal release of acetylcholine by methyl mercury.
    Levesque PC; Atchison WD
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):55-65. PubMed ID: 3376114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dantrolene on tetanic potentiation of MEPP frequency in EGTA containing salines.
    Publicover SJ
    Brain Res; 1982 Dec; 253(1-2):321-4. PubMed ID: 6295555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by Anemonia sulcata toxin II of spontaneous quantal transmitter release from mammalian motor nerve terminals.
    Molgo J; Lemeignan M; Tazieff-Depierre F
    Toxicon; 1986; 24(5):441-50. PubMed ID: 2872736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of quantal transmitter release by the polycationic ligand cationized ferritin.
    Publicover SJ
    Exp Brain Res; 1985; 59(3):629-32. PubMed ID: 2863166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1993 Aug; 468():567-89. PubMed ID: 8254525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous and evoked transmitter releases after concanavalin A treatment are affected differently by hypertonic low calcium solutions at frog neuromuscular junction.
    Narita K; Kawasaki F; Kita H
    Brain Res; 1990 Mar; 512(1):33-9. PubMed ID: 2337806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thiol-oxidizing agent diamide increases transmitter release by decreasing calcium requirements for neuromuscular transmission in the frog.
    Carlen PL; Kosower EM; Werman R
    Brain Res; 1976 Nov; 117(2):257-76. PubMed ID: 186154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effect of calmidazolium (R 24571) on transmitter release at the frog neuromuscular junction.
    Sahaf ZY; Publicover SJ
    Brain Res; 1985 Nov; 348(1):192-6. PubMed ID: 2998560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.